Claire Birrell

1.3k total citations
13 papers, 1.0k citations indexed

About

Claire Birrell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Claire Birrell has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Claire Birrell's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Asthma and respiratory diseases (4 papers). Claire Birrell is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Asthma and respiratory diseases (4 papers). Claire Birrell collaborates with scholars based in United Kingdom, United States and Italy. Claire Birrell's co-authors include Maureen E.M. Benwell, David J.K. Balfour, M. Al-Aloul, René van der Merwe, Christopher E. Brightling, Christine K. Ward, Reynold A. Panettieri, Eugene R. Bleecker, Xiao Xu and Mona Bafadhel and has published in prestigious journals such as British Journal of Pharmacology, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

Claire Birrell

13 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Birrell United Kingdom 12 496 380 380 231 95 13 1.0k
George Apostol United States 17 441 0.9× 169 0.4× 254 0.7× 280 1.2× 198 2.1× 23 1.3k
Jonathan D. Pollock United States 13 333 0.7× 222 0.6× 64 0.2× 57 0.2× 17 0.2× 24 639
Gail Lewandowski United States 13 287 0.6× 284 0.7× 68 0.2× 19 0.1× 118 1.2× 18 950
Zhi Yi Ong Australia 19 110 0.2× 138 0.4× 283 0.7× 61 0.3× 16 0.2× 29 1.0k
Hiroshi Naitoh Japan 15 174 0.4× 150 0.4× 67 0.2× 67 0.3× 83 0.9× 60 683
Miho Nagai Japan 13 168 0.3× 198 0.5× 49 0.1× 76 0.3× 205 2.2× 36 773
Jane A. Stewart United Kingdom 18 355 0.7× 580 1.5× 214 0.6× 39 0.2× 54 0.6× 36 1.3k
Bruce Scharf United States 13 121 0.2× 166 0.4× 44 0.1× 30 0.1× 104 1.1× 28 812
András Horváth Hungary 14 86 0.2× 186 0.5× 220 0.6× 33 0.1× 314 3.3× 53 777
Arata Oh‐Nishi Japan 13 232 0.5× 114 0.3× 120 0.3× 12 0.1× 39 0.4× 28 621

Countries citing papers authored by Claire Birrell

Since Specialization
Citations

This map shows the geographic impact of Claire Birrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Birrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Birrell more than expected).

Fields of papers citing papers by Claire Birrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Birrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Birrell. The network helps show where Claire Birrell may publish in the future.

Co-authorship network of co-authors of Claire Birrell

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Birrell. A scholar is included among the top collaborators of Claire Birrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Birrell. Claire Birrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wollenberg, Andreas, Michael Howell, Emma Guttman‐Yassky, et al.. (2018). A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 2. S29–S29. 12 indexed citations
2.
Sheldon, Eric, Martin Schwickart, Jing Li, et al.. (2016). Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study. Advances in Therapy. 33(2). 225–251. 36 indexed citations
3.
Brightling, Christopher E., Eugene R. Bleecker, Reynold A. Panettieri, et al.. (2014). Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. The Lancet Respiratory Medicine. 2(11). 891–901. 225 indexed citations
4.
Oh, Chad K., Raffaella Faggioni, Feng Jin, et al.. (2010). An open‐label, single‐dose bioavailability study of the pharmacokinetics of CAT‐354 after subcutaneous and intravenous administration in healthy males. British Journal of Clinical Pharmacology. 69(6). 645–655. 53 indexed citations
5.
Oord, Edwin J. C. G. van den, Dan Rujescu, Jaime R. Robles, et al.. (2005). Factor structure and external validity of the PANSS revisited. Schizophrenia Research. 82(2-3). 213–223. 121 indexed citations
6.
Parry‐Billings, Mark, et al.. (2003). Inspiratory flow rate through a dry powder inhaler (Clickhaler®) in children with asthma. Pediatric Pulmonology. 35(3). 220–226. 14 indexed citations
7.
Zussman, Barry D., et al.. (2001). Bioavailability of the Oral Selective Phosphodiesterase 4 Inhibitor Cilomilast. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(6). 653–660. 17 indexed citations
8.
Balfour, David J.K., et al.. (2000). The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behavioural Brain Research. 113(1-2). 73–83. 190 indexed citations
9.
Lyles, Geoffrey A., Claire Birrell, G. Banchelli, & R. Pirisino. (1998). AMPLIFICATION OF α1D-ADRENOCEPTOR MEDIATED CONTRACTIONS IN RAT AORTIC RINGS PARTIALLY DEPOLARISED WITH KCL. Pharmacological Research. 37(6). 437–454. 6 indexed citations
10.
Birrell, Claire, et al.. (1998). The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D -amphetamine. Psychopharmacology. 140(2). 142–149. 47 indexed citations
11.
Balfour, David J.K., et al.. (1998). Sensitization of the Mesoaccumbens Dopamine Response to Nicotine. Pharmacology Biochemistry and Behavior. 59(4). 1021–1030. 135 indexed citations
12.
Balfour, David J.K., et al.. (1996). Effects of acute D-CPPene on mesoaccumbens dopamine responses to nicotine in the rat. European Journal of Pharmacology. 316(2-3). 153–156. 13 indexed citations
13.
Benwell, Maureen E.M., David J.K. Balfour, & Claire Birrell. (1995). Desensitization of the nicotine‐induced mesolimbic dopamine responses during constant infusion with nicotine. British Journal of Pharmacology. 114(2). 454–460. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026